carnitine palmitoyltransferase

car·ni·tine palmi·to·yl·trans·fer·ase

1. an enzyme that reversibly forms acylcarnitines and coenzyme A from carnitine and acylcoenzyme A (often, palmitoyl-CoA); important in fatty acid oxidation. Deficiency of isozyme I results in ketogenesis with hypoglycemia; deficiency of isozyme II affects primarily skeletal muscle.
Farlex Partner Medical Dictionary © Farlex 2012
References in periodicals archive ?
Other mediators act increasing or decreasing thermogenesis, such as the peroxisome proliferator-activated receptor-coactivator (PGC1[alpha]) that regulates the mitochondrial biogenesis and respiratory function (16), and the carnitine palmitoyltransferase 1A (CPT1a), which controls the fatty acid oxidation (17).
The expression levels of 10 genes: retinoid X receptor alpha (RXRA), peroxisome proliferator-activated receptor gamma (PPARG), phospholipid transfer protein (PLTP), stearoylCoA desaturase (SCD), nuclear receptor subfamily 1 group H member 3 (NR1H3), fatty acid binding protein 3 (FABP3), carnitine palmitoyltransferase II (CPT2), acyl-Coenzyme A dehydrogenase long chain (ACADL), acyl-Coenzyme A oxidase 2 branched chain (ACOX2), and fatty acid binding protein 4 (FABP4), showed significant differences in gene expression between the low- and high-marbled groups (p < 0.05) (Table 2).
In neonates, carnitine palmitoyltransferase deficiency is diagnosed in blood using mass spectrometry.
A catalyzed by carnitine palmitoyltransferase (CPT).
We investigated whether the age-related impairment of cardiac fatty acid catabolism occurs, at least partially, through diminished levels of L-carnitine, which would adversely affect carnitine palmitoyltransferase 1 (CPT1), the rate-limiting enzyme for fatty acyl-CoA uptake into mitochondria for beta]-oxidation.
For example, preliminary evidence suggests that carnitine palmitoyltransferase type 1A deficiency, a fatty acid disorder highly prevalent in AN and other indigenous circumpolar populations, might contribute to infant mortality (8).
Background & Purpose: Carnitine Palmitoyltransferase II (CPT2) deficiency (myopathic form) is a rare, progressive adult metabolic myopathy caused by a genetic insufficiency in CPT2 enzyme production.
Carnitine is supplied into the cell by a plasma membrane carnitine transporter commonly referred to as OCTN2, located in the cellular membrane, and three enzymes: carnitine palmitoyltransferase I (CPT I) in the outer mitochondrial membrane; carnitine/acylcarnitine translocase (CACT) within the inner mitochondrial membrane, and carnitine palmitoyltransferase (CPT II) in the inner mitochondrial membrane (carnitine O-palmitoyltransferase EC are responsible for the reversible reaction: acylCoA+carnitine=acylcarnitine+CoA-SH.
The team also observed an increase in these cells of carnitine palmitoyltransferase 1C (CPT1C), a protein usually found only in the brains of healthy individuals.
Fasting during first days of life can trigger disorder in [beta] oxidation of fatty acids--deficiency of carnitine palmitoyltransferase II.
Anaesthetic management of a parturient with carnitine palmitoyltransferase 2 deficiency.
Full browser ?